Overview
Jorge Aragon practices practicing medicine in Mexico City, Mexico.
Mr. Aragon is highly rated in 1 condition, according to our data. His clinical expertise encompasses Duchenne Muscular Dystrophy and Becker Muscular Dystrophy.
He is actively involved in clinical research, co-authoring 18 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Jorge Aragon
Is Jorge Aragon a top-rated expert for Duchenne Muscular Dystrophy?
MediFind is an objective health platform that identifies experts based on real-world data. Jorge Aragon is classified as an Advanced expert for Duchenne Muscular Dystrophy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Jorge Aragon participate in research or clinical trials?
Yes. Jorge Aragon has published 18 articles and abstracts on conditions like Duchenne Muscular Dystrophy. You can view a list of Jorge Aragon's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Duchenne Muscular DystrophyMr. Aragon isAdvanced. Learn about Duchenne Muscular Dystrophy.
- Experienced
- Becker Muscular DystrophyMr. Aragon isExperienced. Learn about Becker Muscular Dystrophy.